Antiviral agent


All relevant publications

Antiviral agent

Virus-host interaction

Published by Eike Steinmann, Mara Klöhn

The hepatitis E virus (HEV) is the main cause of acute viral hepatitis. Approximately 70,000 people die from the disease every year, yet therapy options remain limited. In the pursuit of effective ant...


Antiviral agent

Published by Wenshi Wang

Hepatitis E virus (HEV) infection can cause severe complications and high mortality in pregnant women, organ transplant recipients, patients with pre-existing liver disease and immunosuppressed patien...


Antiviral agent

Published by Mohammad Khalid Parvez

In the absence of a globally accessible HEV vaccine, peg-IFNα-2a and ribavirin are the only effective regimen of choice for acute hepatic failure and chronic hepatitis E. However, though ribavirin in...


Antiviral agent

Published by Mohammad Khalid Parvez

Globally, pegylated interferon-α and ribavirin are the only recommended antiviral agents for treating chronic hepatitis E patients. However, though ribavirin induces a sustained virologic response, s...


Antiviral agent

Published by Yunlong Li

On 30 August, Yunlong Li defended his PhD thesis on the development of antiviral therapy for treating hepatitis E virus (HEV) infection at Erasmus University Rotterdam, the Netherlands.  ...


Antiviral agent

Published by Mohammad Khalid Parvez

HEV has been recognized with eight genotypes (HEV1- HEV8), of which HEV1-HEV4 are infectious to humans. While HEV1 is waterborne infection causing self-limiting acute hepatitis E in general population...


Antiviral agent

Published by Mara Klöhn, Eike Steinmann

Every year, an estimated 20 million people become infected with HEV, resulting in 3.3 million acute cases and approximately 70,000 deaths annually, making HEV the leading cause for acute viral hepatit...


0 - 7 of 7 items
1  

MEMBERS

GHEP offers free membership for your better connection with the hepatitis E community

EVENTS

2025-01-18

International Joint Meeting on Viral Infections of the Liver and the Heart (2025)
Day two of this symposium will place a special emphasis on Hepatitis E — a virus that, despite being the most common cause of viral hepatitis, offers a valuable opportunity for further research and understanding. Venue: Cantinerie Berlin Gustav-Meyer-Allee 25 13355 Berlin, Germany. Organisers: Prof. Dr. Jens Kurreck, Dr. rer. nat. Daniel Todt, Prof. Dr. med. Heiner Wedemeyer, More information: Medizinische Hochschule Hannover : International DFG/DZIF Joint Meeting on Viral Infections of the Liver and the Heart (mhh.de)